Q4 2017 Holdings
Filed 2018-02-14 | 43 holdings | $77.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $46.6M | 5,721,888 | 59.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $23.7M | 1,124,483 | 30.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $4.8M | 459,396 | 6.1% |
| Anthera Pharmaceuticals Inc(ANTH) | COM | 03674U300 | $2.0M | 1,216,403 | 2.6% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $111.2K | 8,686,498 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $59.9K | 594,397 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $57.9K | 767,354 | 0.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $53.5K | 1,502,800 | 0.1% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $51.0K | 1,969,789 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $45.1K | 7,587,416 | 0.1% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $28.3K | 25,995,575 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $28.3K | 3,233,618 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $27.1K | 16,436,912 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $23.0K | 8,596,357 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $20.7K | 1,353,846 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $19.8K | 9,766,508 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $19.8K | 2,623,562 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $17.5K | 4,271,289 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $14.5K | 13,974,249 | 0.0% |
| GTX Inc del | COM NEW | 40052B207 | $14.1K | 1,107,433 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $13.8K | 625,000 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $13.2K | 3,100,000 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $12.6K | 3,455,117 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $12.1K | 1,029,185 | 0.0% |
| Cascadian Therapeutics Inc | COM NEW | 14740B606 | $11.6K | 3,133,224 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $11.1K | 823,474 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.1K | 3,588,830 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $8.4K | 497,474 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.6K | 675,759 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $7.5K | 2,043,196 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $7.3K | 724,132 | 0.0% |
| Verastem Inc | COM | 92337C104 | $6.9K | 2,250,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.1K | 294,117 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $5.7K | 1,469,800 | 0.0% |
| Tocagen Inc | COM | 888846102 | $5.7K | 556,683 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $4.6K | 1,608,433 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $4.0K | 273,350 | 0.0% |
| Orexigen Therapeutics Inc | NOTE 2.750%12/0 | 686164AB0 | $3.6K | $10,000,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $3.5K | 3,500,000 | 0.0% |
| Vical Inc | COM NEW | 925602203 | $2.6K | 1,409,444 | 0.0% |
| Pain Therapeutics Inc | COM NEW | 69562K506 | $1.3K | 325,509 | 0.0% |
| Orexigen Therapeutics Inc | COM NEW | 686164302 | $948 | 734,976 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $369 | 4,386 | 0.0% |